Stocklytics Platform
Asset logo for symbol CLBTW
Cellebrite DI Ltd.
CLBTW4
$5.24arrow_drop_down11.78%-$0.70
Asset logo for symbol CLBTW
CLBTW4

$5.24

arrow_drop_down11.78%

Performance History

Chart placeholder
Key Stats
Open$5.70
Prev. Close$5.95
EPS0.05
Next Earnings Date-
Dividend Yield %-
Market Cap-
LOWHIGH
Day Range4.50
5.90
52 Week Range0.72
6.06
Ratios
Revenue-
EPS0.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Cellebrite DI Ltd. (CLBTW)

Cellebrite DI Ltd., also known as CLBTW, is a leading provider of digital intelligence solutions. The company specializes in data extraction, analysis, and reporting for law enforcement and intelligence agencies. With its advanced technology and expertise, Cellebrite DI Ltd. helps investigators uncover critical information from mobile devices, social media platforms, and other digital sources.
As of the latest stock price history, CLBTW has shown steady growth over the years. Investors have been attracted to the company's innovative solutions and its ability to address the growing need for digital intelligence. The stock has experienced a significant increase in value, making it an attractive investment opportunity.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Cellebrite DI Ltd. to watchlist

Keep an eye on Cellebrite DI Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Cellebrite DI Ltd.'s (CLBTW) price per share?

The current price per share for Cellebrite DI Ltd. (CLBTW) is $5.25. The stock has seen a price change of -$0.7 recently, indicating a -11.79% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Cellebrite DI Ltd. (CLBTW)?

For Cellebrite DI Ltd. (CLBTW), the 52-week high is $6.06, which is 15.46% from the current price. The 52-week low is $0.72, the current price is 628.97% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Cellebrite DI Ltd. (CLBTW) a growth stock?

Cellebrite DI Ltd. (CLBTW) has shown an average price growth of -3.55% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cellebrite DI Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Cellebrite DI Ltd. (CLBTW) stock price performance year to date (YTD)?

As of the latest data, Cellebrite DI Ltd. (CLBTW) has a year-to-date price change of 234.31%. Over the last three months, the change has been 43.8%. Over the past six months, the figure is 115.99%.
help

Is Cellebrite DI Ltd. (CLBTW) a profitable company?

Cellebrite DI Ltd. (CLBTW) has a net income of -$81.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.05% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 20.12%, providing insight into the company's sales performance and growth. The gross profit is $271.88M. Operating income is noted at $33.28M. Furthermore, the EBITDA is $60.96M.
help

What is the market capitalization of Cellebrite DI Ltd. (CLBTW)?

Cellebrite DI Ltd. (CLBTW) has a market capitalization of . The average daily trading volume is 269.02K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level